Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster - Wang, Qian; Mellis, Ian A.; Guo, Yicheng; Gherasim, Carmen; Valdez, Riccardo; Gordon, Aubree; Ho, David D.; Liu, Lihong (Cell reports. Medicine, 2024)
Keywords: Adult; Advanced Basic Science; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; antibody decay rate; COVID-19; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 - virology; COVID-19 Vaccines - administration & dosage; COVID-19 Vaccines - immunology; Female; Humans; Immunization, Secondary; Male; Middle Aged; mRNA Vaccines - immunology; Neutralization Tests; neutralizing antibody responses; Omicron subvariant JN.1; SARS-CoV-2; SARS-CoV-2 - immunology; Spike Glycoprotein, Coronavirus - immunology; XBB.1.5 monovalent mRNA vaccine; COVID-19; XBB.1.5 monovalent mRNA vaccine; antibody decay rate; SARS-CoV-2; neutralizing antibody responses; Omicron subvariant JN.1